Newsfeeds Archive - Spark Newswire

4 minute read

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

June 20, 1:26 PM

Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday’s session following third-quarter results. Jabil reported third-quarter fiscal 2024…

ALUR

1 minute read

Movers
News

Why ImmunityBio Stock Is Trading Higher Thursday

By Dylan Berman

June 20, 12:49 PM

The company announced insurance coverage of ANKTIVA, a immunotherapy used to treat non-muscle invasive bladder cancer that was unresponsive to other specific treatments.

IBRX

2 minute read

KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday

By Avi Kapoor

June 20, 10:21 AM

U.S. stocks were mixed, with the Dow Jones index gaining around 150 points on Thursday. Shares of KB…

ACN

5 minute read

Options

10 Health Care Stocks With Whale Alerts In Today’s Session

By Benzinga Insights

June 11, 1:35 PM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…

ABBV

2 minute read

How Is The Market Feeling About ImmunityBio?

By Benzinga Insights

May 17, 4:30 PM

ImmunityBio’s (NYSE:IBRX) short percent of float has fallen 8.79% since its last report. The company recently reported that…

IBRX

3 minute read

Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday

By Avi Kapoor

May 7, 10:53 AM

U.S. stocks were higher, with the Dow Jones gaining over 80 points on Tuesday. Shares of Tempur Sealy…

ADTN

3 minute read

ImmunityBio Completes GMP Drug Substance Manufacturing Sufficient For 170,000 Doses Of ANKTIVA

By Benzinga Newsdesk

May 7, 8:18 AM

ANKTIVA® Drug Substance completed and released with two-year storage stability data sufficient for 170,000 doses of ANKTIVA productImmunityBio's 400,000 square foot GMP fill-finish facility in Dunkirk, New York on

IBRX

2 minute read

Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio’s Bladder Cancer Combo Therapy

By Vandana Singh

May 3, 12:19 PM

Unlocking global access to Bacillus Calmette-Guerin (BCG) for cancer therapy. ImmunityBio partners with Serum Institute to expand BCG supply. FDA-approved Anktiva plus BCG for bladder cancer.

IBRX

3 minute read

Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday

By Avi Kapoor

May 3, 10:15 AM

U.S. stocks were higher, with the Dow Jones index gaining over 400 points on Friday. Shares of Amgen…

AAPL

4 minute read

ImmunityBio, Serum Institute Of India Agree On An Exclusive Arrangement For Global Supply Of Bacillus Calmette-Guerin Across All Cancer Types

By Benzinga Newsdesk

May 2, 4:45 PM

Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio's recently approved treatment for non-muscle invasive bladder cancer (NMIBC)Serum Institute of India

IBRX